Glue to the Rescue: Evaluation of Cyanoacrylate to Improve Dressing Adherence, Hemostasis and Central Line-Associated Bloodstream Infections of Central Venous Catheters
The purpose of this quality improvement (QI) project was to evaluate the effectiveness of cyanoacrylate in reducing early dressing changes as well as central line-associated bloodstream infections (CLABSI) for internal jugular (IJ) introducers and non-tunneled dialysis catheters, with secondary outcomes being staff satisfaction and cost implications.
Central line-associated bloodstream infection (CLABSI) causes 150 excess deaths for every 1,000 in hospital cases, with an average additional cost of $48,108. Between May 2020 and April 2021, the Cardiovascular Intensive Care Unit (CVICU) was above the desired benchmark for patients who developed a hospital-acquired CLABSI. Patients in the CVICU often require continuous anticoagulation as well as an introducer and/or non-tunneled dialysis central venous access devices (CVAD) most often in the IJ location. Keeping these CVAD dressings clean, dry and intact...